Pharmaceuticals distributor Cardinal Health (NYSE: CAH) reported a 36% YoY growth in adjusted earnings for the second quarter of fiscal 2026, driven by a double-digit increase in revenues.
- Second-quarter revenue increased 19% year-over-year to $65.6 billion, benefiting from strong performance by the Pharmaceutical and Specialty Solutions segment
- Net earnings attributable to the company were $467 million in Q2, up 17% year-over-year
- On a per-share basis, second-quarter net income rose sharply to $1.97 per share from $1.65 per share in Q2 2025
- Adjusted earnings climbed 36% to $2.63 per share in Q2 from $1.93 per share in the year-ago quarter
- Operating earnings increased 29% from last year to $707 million during the three months
- The management raised its fiscal 2026 earnings per share guidance, on an adjusted basis, to $10.15-10.35
- In the second quarter, the company completed its annual baseline share repurchase of $750 million
Advertisement
